lithium has been researched along with oxidopamine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (83.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodt, C; Gross, G; Hanft, G | 1 |
| Bright, PS; Gaffney, TE; Street, JA; Webb, JG | 1 |
| Koob, GF; Lee, D; Swerdlow, NR; Vaccarino, FJ | 1 |
| Bloom, FE; Deyo, SN; Magistretti, PJ; Shoemaker, WJ; Staunton, DA | 1 |
| Foley, DH | 1 |
| Baetge, G; Bloom, FE; Deyo, S; Ettenberg, A; Koda, L; Magistretti, PJ; Shoemaker, WJ; Staunton, DA | 1 |
| Grisham, JE; Kozlowski, MR; Marshall, JF; Neve, KA | 1 |
| Mailman, RB | 1 |
| Gruenthal, M | 1 |
| Petty, F; Sherman, AD | 1 |
| Bals-Kubik, R; Herz, A; Shippenberg, TS | 1 |
| Ding, H; Fan, Z; Ke, ZJ; Luo, J; Yong, Y | 1 |
1 review(s) available for lithium and oxidopamine
| Article | Year |
|---|---|
Chemical and physiological aspects of the actions of lithium and antidepressant drugs.
Topics: Animals; Antidepressive Agents; Apomorphine; Blood Pressure; Brain Chemistry; Diet; Endorphins; Haloperidol; Humans; Hydroxydopamines; Hypertension; Lithium; Motor Activity; Oxidopamine; Rats; Receptors, Dopamine; Stereotyped Behavior | 1983 |
11 other study(ies) available for lithium and oxidopamine
| Article | Year |
|---|---|
Effect of chronic lithium administration on adrenoceptor binding and adrenoceptor regulation in rat cerebral cortex.
Topics: Animals; Cerebral Cortex; Desipramine; Dihydroalprenolol; Hydroxydopamines; In Vitro Techniques; Injections, Intraventricular; Lithium; Male; Oxidopamine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Sympathectomy, Chemical; Yohimbine | 1988 |
Depolarization-induced release of propranolol and atenolol from rat cortical synaptosomes.
Topics: Animals; Atenolol; Calcium; Cerebral Cortex; Cesium; Hydroxydopamines; In Vitro Techniques; Lithium; Male; Membrane Potentials; Neuromuscular Depolarizing Agents; Norepinephrine; Oxidopamine; Potassium; Propranolol; Rats; Rubidium; Synaptosomes; Tetrodotoxin; Time Factors; Veratridine | 1985 |
Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat.
Topics: Animals; Apomorphine; Behavior, Animal; Body Weight; Caudate Nucleus; Diet; Hydroxydopamines; Lithium; Male; Motor Activity; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Sympathectomy, Chemical | 1985 |
Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Chlorides; Corpus Striatum; Dopamine; Haloperidol; Humans; Hydroxydopamines; Kinetics; Lithium; Lithium Chloride; Male; Motor Activity; Neural Pathways; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra | 1982 |
Diminished arterial smooth muscle response to adenosine during Na-K pump inhibition.
Topics: Adenosine; Animals; Arteries; Chlorides; Hydroxydopamines; Ion Channels; Lithium; Lithium Chloride; Male; Muscle, Smooth, Vascular; Ouabain; Oxidopamine; Potassium; Rabbits; Sodium | 1984 |
Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites.
Topics: Animals; Behavior, Animal; Butyrophenones; Corpus Striatum; Dominance, Cerebral; Dopamine; Frontal Lobe; Hydroxydopamines; Lithium; Lithium Carbonate; Male; Nerve Regeneration; Neural Pathways; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Substantia Nigra; Touch | 1983 |
Lithium-induced polydipsia: dependence on nigrostriatal dopamine pathway and relationship to changes in the renin-angiotensin system.
Topics: Angiotensin II; Animals; Brain Chemistry; Catecholamines; Corpus Striatum; Dopamine; Drinking Behavior; Hydroxydopamines; Lithium; Male; Neural Pathways; Oxidopamine; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Substantia Nigra | 1983 |
Lithium attenuates the development of lesion-induced behavioral supersensitivity to apomorphine.
Topics: Animals; Apomorphine; Body Weight; Corpus Striatum; Dopamine; Hydroxydopamines; Lithium; Male; Movement; Oxidopamine; Rats; Rats, Inbred Strains; Rotation; Substantia Nigra | 1984 |
A pharmacologically pertinent animal model of mania.
Topics: Affective Disorders, Psychotic; Animals; Bipolar Disorder; Disease Models, Animal; Electroshock; Humans; Hydroxydopamines; Imipramine; Injections, Intraventricular; Lactates; Lactic Acid; Lithium; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains | 1981 |
Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
Topics: Animals; Benzazepines; Chlorides; Conditioning, Classical; Dopamine; Dopamine D2 Receptor Antagonists; Lithium; Lithium Chloride; Male; Morphine; Motivation; Narcotics; Neurons; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1993 |
Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium; Male; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Sympatholytics | 2011 |